.
Techulon is a life sciences company with a core capability in the development, characterization and synthesis of novel gene delivery techniques for cell-based therapeutics. In addition to reagent sales to research laboratories, Techulon co-develops delivery platforms for license by pharmaceutical companies.
Techulon’s platform technologies are polymer-based nanoparticles that deliver DNA and RNA into cells with lower cell toxicity and high expression profiles. The company is focused on delivery for therapeutically relevant cells such as primary cells. Applications for this new technology range from research on cellular metabolism to advanced forms of cancer treatment.